These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8713009)

  • 21. Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience.
    Stefoni V; Broccoli A; Argnani L; Sabattini E; Cavo M; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):297-299. PubMed ID: 29500149
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous plasmacytoma: report of a case with review of the literature.
    Muscardin LM; Pulsoni A; Cerroni L
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):962-5. PubMed ID: 11044834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous B-cell lymphomas.
    Prince HM; Yap LM; Blum R; McCormack C
    Clin Exp Dermatol; 2003 Jan; 28(1):8-12. PubMed ID: 12558619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary cutaneous B cell lymphoma: classification and current status of treatment].
    Hase T
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):556-9. PubMed ID: 21553554
    [No Abstract]   [Full Text] [Related]  

  • 26. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous lymphoma: local control and survival in patients treated with radiotherapy.
    De Sanctis V; Osti MF; Berardi F; Ardito F; Valeriani M; Martelli M; Enrici RM
    Anticancer Res; 2007; 27(1B):601-5. PubMed ID: 17348448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary cutaneous B-cell lymphoma. Diagnosis, treatment, and prognosis.
    Watsky KL; Longley BJ; Dvoretzky I
    J Dermatol Surg Oncol; 1992 Nov; 18(11):951-4. PubMed ID: 1430551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large B-cell lymphoma of the leg.
    Vasquez-del-Mercado E; Toussaint S; de La Barreda F; Ortiz-Hidalgo C
    Int J Dermatol; 2001 Oct; 40(10):648-7. PubMed ID: 11737426
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case].
    Grau E; Real E; Perella M; Escandon J; Pastor E; Gómez A
    Sangre (Barc); 1997 Jun; 42(3):231-3. PubMed ID: 9381268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy.
    Massengale WT; McBurney E; Gurtler J
    J Am Acad Dermatol; 2002 Mar; 46(3):441-3. PubMed ID: 11862185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous B-cell lymphoma].
    Gellrich S; Muche JM; Audring H; Sterry W
    Hautarzt; 2000 May; 51(5):363-73; quiz 373-5. PubMed ID: 10875080
    [No Abstract]   [Full Text] [Related]  

  • 34. Ga-67 uptake in cutaneous B-cell lymphoma.
    Assassa GS; Siegel ME; Chen DC; Ansari A
    Clin Nucl Med; 1994 Jul; 19(7):614-6. PubMed ID: 7924104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
    Kasper RC; Wood GS; Nihal M; LeBoit PE
    Am J Dermatopathol; 2001 Apr; 23(2):124-32. PubMed ID: 11285407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant lymphoma of the skin].
    Kerl H; Volkenandt M; Cerroni L
    Hautarzt; 1994 Jun; 45(6):421-43; quiz 441-2. PubMed ID: 8071078
    [No Abstract]   [Full Text] [Related]  

  • 37. Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody.
    Soda R; Costanzo A; Cantonetti M; Orlandi A; Bianchi L; Chimenti S
    Acta Derm Venereol; 2001; 81(3):207-8. PubMed ID: 11558880
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
    Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
    J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma.
    Cerroni L; El-Shabrawi-Caelen L; Fink-Puches R; LeBoit PE; Kerl H
    Am J Dermatopathol; 2000 Aug; 22(4):299-304. PubMed ID: 10949453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].
    Lamos C; Dippel E
    Hautarzt; 2017 Sep; 68(9):727-739. PubMed ID: 28815289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.